600352:SSEZhejiang Longsheng Group Co. Ltd. Class A Analysis
Data as of 2026-03-16 - not real-time
CN¥14.94
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Zhejiang Longsheng’s share price sits well below its discounted cash‑flow estimate, making the stock appear markedly cheap on a valuation basis. The price‑earnings multiple sits in the high‑twenties while the forward multiple is in the high‑teens, and the dividend yield exceeds three percent, but the payout ratio is above one, raising questions about dividend sustainability. Revenue has been contracting and gross margins are modest, yet operating cash flow remains robust and the company holds a sizable cash balance, offset by a debt load that is high relative to equity.
On the technical side, the price is above its fifty‑day moving average but below the twenty‑day average, and the SMA hierarchy (20 > 50 > 200) points to a bullish medium‑term trend. However, the MACD shows bearish momentum and the RSI hovers near the midpoint, while volume has been slipping and recent volatility is elevated. Beta is low, suggesting limited sensitivity to broader market moves, but sector‑specific and regulatory risks in specialty chemicals, combined with concentration in China, add a moderate‑to‑high risk overlay.
On the technical side, the price is above its fifty‑day moving average but below the twenty‑day average, and the SMA hierarchy (20 > 50 > 200) points to a bullish medium‑term trend. However, the MACD shows bearish momentum and the RSI hovers near the midpoint, while volume has been slipping and recent volatility is elevated. Beta is low, suggesting limited sensitivity to broader market moves, but sector‑specific and regulatory risks in specialty chemicals, combined with concentration in China, add a moderate‑to‑high risk overlay.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near immediate support level
- bearish MACD divergence
- elevated short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- substantial undervaluation versus intrinsic estimate
- strong cash generation relative to debt
- attractive dividend yield despite sustainability concerns
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- persistent revenue contraction
- high debt burden
- cyclical nature of specialty chemicals sector
Key Metrics & Analysis
Financial Health
Revenue Growth-13.40%
Profit Margin13.88%
P/E Ratio23.3
ROE6.42%
ROA1.48%
Debt/Equity56.44
P/B Ratio1.4
Op. Cash FlowCN¥11.0B
Free Cash FlowCN¥9.6B
Technical Analysis
TrendBullish
RSI47.3
SupportCN¥13.90
ResistanceCN¥17.11
MA 20CN¥16.03
MA 50CN¥13.76
MA 200CN¥11.24
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair ValueCN¥40.25
GradeUndervalued
TypeValue
Dividend Yield3.01%
Risk Assessment
Beta0.10
Volatility65.54%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.